Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia.
Bäumer N, Scheller A, Wittmann L, Faust A, Apel M, Nimmagadda SC, Geyer C, Grunert K, Kellmann N, Peipp M, Kailayangiri S, Gutierrez Suburu ME, Strassert CA, Schenk M, Greune L, Rüter C, Dersch P, Hartmann W, Rossig C, Neri D, Müller-Tidow C, Schwöppe C, Schliemann C, Khandanpour C, Lenz G, Berdel WE, Bäumer S. Bäumer N, et al. Among authors: schwoppe c. J Hematol Oncol. 2022 Dec 1;15(1):171. doi: 10.1186/s13045-022-01390-5. J Hematol Oncol. 2022. PMID: 36457063 Free PMC article.
Generation of fusion proteins for selective occlusion of tumor vessels.
Kessler T, Schwöppe C, Liersch R, Schliemann C, Hintelmann H, Bieker R, Berdel WE, Mesters RM. Kessler T, et al. Among authors: schwoppe c. Curr Drug Discov Technol. 2008 Mar;5(1):1-8. doi: 10.2174/157016308783769487. Curr Drug Discov Technol. 2008. PMID: 18537561
Compounds in clinical Phase III and beyond.
Kessler T, Bayer M, Schwöppe C, Liersch R, Mesters RM, Berdel WE. Kessler T, et al. Among authors: schwoppe c. Recent Results Cancer Res. 2010;180:137-63. doi: 10.1007/978-3-540-78281-0_9. Recent Results Cancer Res. 2010. PMID: 20033382 Review.
Tissue-factor fusion proteins induce occlusion of tumor vessels.
Schwöppe C, Kessler T, Persigehl T, Liersch R, Hintelmann H, Dreischalück J, Ring J, Bremer C, Heindel W, Mesters RM, Berdel WE. Schwöppe C, et al. Thromb Res. 2010 Apr;125 Suppl 2:S143-50. doi: 10.1016/S0049-3848(10)70033-5. Thromb Res. 2010. PMID: 20433995
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.
Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-Tidow C, Berdel WE, Mesters R. Liersch R, et al. Among authors: schwoppe c. Blood. 2012 May 31;119(22):5215-20. doi: 10.1182/blood-2011-11-389692. Epub 2012 Apr 17. Blood. 2012. PMID: 22510874 Free article. Clinical Trial.
42 results